A Model for Targeting Colon Carcinoma Cells Using Single-Chain Variable Fragments Anchored on Virus-Like Particles via Glycosyl Phosphatidylinositol Anchor

[1]  E. Park,et al.  Display of Neospora caninum surface protein related sequence 2 on Rous sarcoma virus-derived gag protein virus-like particles. , 2013, Journal of biotechnology.

[2]  D. W. Pack,et al.  Design of hybrid lipid/retroviral-like particle gene delivery vectors. , 2013, Molecular pharmaceutics.

[3]  Jijin Gu,et al.  Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel. , 2013, Biomaterials.

[4]  Jijin Gu,et al.  Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel. , 2013, Biomaterials.

[5]  D. Powell,et al.  Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody , 2011, PloS one.

[6]  E. Park,et al.  Expression of an RSV-gag virus-like particle in insect cell lines and silkworm larvae. , 2011, Journal of virological methods.

[7]  V. Kadambi,et al.  Antibody drug conjugates - Trojan horses in the war on cancer. , 2011, Journal of pharmacological and toxicological methods.

[8]  Zhaofei Li,et al.  Autographa californica Multiple Nucleopolyhedrovirus GP64 Protein: Roles of Histidine Residues in Triggering Membrane Fusion and Fusion Pore Expansion , 2011, Journal of Virology.

[9]  E. Park,et al.  Production of Rous sarcoma virus-like particles displaying human transmembrane protein in silkworm larvae and its application to ligand-receptor binding assay. , 2011, Journal of biotechnology.

[10]  Manuel Arruebo,et al.  Assessment of the Evolution of Cancer Treatment Therapies , 2011, Cancers.

[11]  Azam Bolhassani,et al.  Improvement of different vaccine delivery systems for cancer therapy , 2011, Molecular Cancer.

[12]  I. Morita,et al.  Preparation of connexin43‐integrated giant Liposomes by a baculovirus expression–liposome fusion method , 2010, Biotechnology and bioengineering.

[13]  R. Arora,et al.  GPI-anchored single chain Fv - an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike , 2010, Retrovirology.

[14]  K. Tsumoto,et al.  Confocal microscopic observation of fusion between baculovirus budded virus envelopes and single giant unilamellar vesicles. , 2010, Biochimica et biophysica acta.

[15]  E. Freed,et al.  The Role of Lipids in Retrovirus Replication , 2010, Viruses.

[16]  Shufang Zhang,et al.  Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. , 2010, Biomaterials.

[17]  Etienne Weiss,et al.  Therapeutic antibodies: successes, limitations and hopes for the future , 2009, British journal of pharmacology.

[18]  Pier Luigi Martelli,et al.  PredGPI: a GPI-anchor predictor , 2008, BMC Bioinformatics.

[19]  G. Medina,et al.  Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. , 2008, Virology.

[20]  G. Heijne,et al.  Molecular code for transmembrane-helix recognition by the Sec61 translocon , 2007, Nature.

[21]  P. Houghton,et al.  The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. , 2007, Methods.

[22]  B. Seed,et al.  Direct stimulation of T lymphocytes by immunosomes: Virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules , 2006, Proceedings of the National Academy of Sciences.

[23]  E. Park,et al.  Construction of hybrib Autographa californica nuclear polyhedrosis bacmid by modification of p143 helicase. , 2006, Journal of virological methods.

[24]  L. Babe,et al.  Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT). , 2006, Bioconjugate chemistry.

[25]  Masahito Yamazaki,et al.  Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability. , 2005, Biochemistry.

[26]  Niklaus Fankhauser,et al.  Identification of GPI anchor attachment signals by a Kohonen self-organizing map , 2005, Bioinform..

[27]  V. Vogt,et al.  Rous Sarcoma Virus Gag Protein-Oligonucleotide Interaction Suggests a Critical Role for Protein Dimer Formation in Assembly , 2002, Journal of Virology.

[28]  P. Bütikofer,et al.  GPI‐anchored proteins: now you see ’em, now you don’t , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  L. Weiner,et al.  Bispecific antibodies in cancer therapy. , 1999, Current opinion in immunology.

[30]  G W Beresford,et al.  Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  G. Blissard,et al.  The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection , 1996, Journal of virology.

[32]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[33]  G. Blissard,et al.  The baculovirus GP64 envelope fusion protein: synthesis, oligomerization, and processing. , 1995, Virology.

[34]  G. Blissard,et al.  Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein , 1995, Journal of virology.

[35]  S. Ohnishi,et al.  Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes , 1980, FEBS letters.

[36]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.